Urologic Oncology: Analysis and Treatment
A special issue of Uro (ISSN 2673-4397).
Deadline for manuscript submissions: closed (15 July 2024) | Viewed by 2925
Special Issue Editor
Special Issue Information
Dear Colleagues,
"Urologic Oncology: Analysis and Treatment" is a Special Issue dedicated to the study and management of cancers affecting the urinary system, including the kidneys, bladder, prostate, and related organs. The Special Issue’s core focus is to provide a platform for researchers and clinicians to share their latest findings and experiences in urologic oncology. It encompasses a wide range of topics, from epidemiology and diagnostics to various treatment modalities (surgery, radiation, chemotherapy, and immunotherapy) and their outcomes.
This Special Issue situates itself within the existing urologic oncology literature by contributing new research, clinical insights, and perspectives. Authors are encouraged to reference relevant studies and guidelines, aligning their work with the field's latest developments and best practices. The goal is to foster knowledge exchange, enhancing patient care and outcomes in urologic oncology. Ultimately, this Special Issue advances the field by facilitating idea sharing, methodologies, and experiences among experts. It supports ongoing improvements in urologic cancer management while providing a valuable resource for the broader medical and research community.
Dr. Haoyue Sheng
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Uro is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urologic oncology
- cancer treatment
- urinary system
- kidney cancer
- bladder cancer
- prostate cancer
- diagnosis and screening
- treatment modalities
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.